UNSPSC 85494116: Revision of autologous tissue substitute in aortic valve, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in aortic valve, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 02WF07Z

UNSPSC 85494116 Revision of autologous tissue substitute in aortic valve, open approach (Commodity) shows minimal alignment between the code's nominal medical device scope and the recent state and local opportunities posted under it. The six opportunities actually solicited span occupational medical surveillance, independent disability medical evaluations, surgical care carve-out benefit programs, pharmacy benefit management, emergency and specialty healthcare for detained youth, and temporary health professional staffing — none of which involve autologous tissue substitutes or aortic valve procedures. State and local procurement offices appear to have misclassified these opportunities when tagging them to this code, or the code itself has been applied inconsistently across different issuing systems.

The geographic spread of recent activity includes Arizona (City of Phoenix), California (City of Long Beach, County of Santa Clara), Washington State (Washington State Department of Transportation), Florida (Collier County), and Texas (Harris County), with response deadlines clustering between early October and mid-November 2026. Representative opportunities include the City of Phoenix Retirement Office RFP for independent medical evaluation services (RTMRFP26001, due October 16, 2026, $750,000 over five years), the Washington State Department of Transportation RFP for occupational medical surveillance services (RFP20260825, due October 9, 2026), and the County of Santa Clara Health System qualification solicitation for temporary health professional staffing across thirteen clinical and ancillary categories (RFSQHHSFY270052, due October 7, 2026). The code does not represent a cohesive procurement family and warrants recategorization before pursuing opportunities within it.